tiprankstipranks
Trending News
More News >
Abeona Therapeutics (ABEO)
NASDAQ:ABEO
US Market

Abeona Therapeutics (ABEO) Financial Statements

Compare
1,477 Followers

Abeona Therapeutics Financial Overview

Abeona Therapeutics's market cap is currently $281.25M. The company's EPS TTM is $-0.1; its P/E ratio is 4.68; Abeona Therapeutics is scheduled to report earnings on November 12, 2025, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 3.50M$ 1.41M$ 3.00M$ 10.00M
Gross Profit$ -2.91M$ 1.90M$ 964.00K$ 3.00M$ 10.00M
Operating Income$ -64.21M$ -47.13M$ -50.91M$ -89.84M$ -81.42M
EBITDA$ -56.62M$ -50.57M$ -34.38M$ -76.82M$ -74.52M
Net Income$ -63.73M$ -54.19M$ -39.70M$ -84.94M$ -84.23M
Balance Sheet
Cash & Short-Term Investments$ 97.72M$ 52.23M$ 52.15M$ 45.02M$ 95.03M
Total Assets$ 108.93M$ 64.00M$ 64.21M$ 79.59M$ 151.20M
Total Debt$ 23.05M$ 5.40M$ 7.63M$ 9.38M$ 8.73M
Net Debt$ -309.00K$ -9.07M$ -6.59M$ -23.56M$ -3.87M
Total Liabilities$ 64.90M$ 49.18M$ 37.45M$ 37.22M$ 48.65M
Stockholders' Equity$ 44.03M$ 14.83M$ 26.76M$ 42.37M$ 102.55M
Cash Flow
Free Cash Flow$ -58.46M$ -37.34M$ -43.61M$ -69.82M$ -36.35M
Operating Cash Flow$ -56.02M$ -37.01M$ -43.48M$ -65.67M$ -35.02M
Investing Cash Flow$ -39.24M$ 208.00K$ -23.96M$ 66.06M$ -83.71M
Financing Cash Flow$ 104.14M$ 37.06M$ 43.17M$ 24.86M$ 1.94M
Currency in USD

Abeona Therapeutics Earnings and Revenue History

Abeona Therapeutics Debt to Assets

Abeona Therapeutics Cash Flow

Abeona Therapeutics Forecast EPS vs Actual EPS